Home / Market Reports / Pharma & Healthcare / Global Veterinary Immunomodulators Market Growth 2024-2030

Global Veterinary Immunomodulators Market Growth 2024-2030

Global Veterinary Immunomodulators Market Growth 2024-2030

Product Code:1242024

Published Date: Dec 04,2024

Pages: 102

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global Veterinary Immunomodulators market size is predicted to grow from US$ 1147 million in 2024 to US$ 1609 million in 2030; it is expected to grow at a CAGR of 5.8% from 2024 to 2030.

Veterinary Immunomodulators are substances or drugs used to regulate or modify the immune system of animals. They are typically used in veterinary medicine to enhance or suppress the immune response in animals that are suffering from immune-related disorders or infections. Immunomodulators can help boost the animal's ability to fight infections, control autoimmune diseases, or regulate allergic reactions. They are often prescribed when an animal's immune system is either underactive (leading to infections) or overactive (leading to autoimmune or inflammatory diseases).

United States market for Veterinary Immunomodulators is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Veterinary Immunomodulators is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Veterinary Immunomodulators is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Veterinary Immunomodulators players cover Zoetis, Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, MSD Animal Health, ImmunoVet Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Veterinary Immunomodulators Industry Forecast” looks at past sales and reviews total world Veterinary Immunomodulators sales in 2023, providing a comprehensive analysis by region and market sector of projected Veterinary Immunomodulators sales for 2024 through 2030. With Veterinary Immunomodulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Immunomodulators industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Immunomodulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Immunomodulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Immunomodulators market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Immunomodulators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Immunomodulators.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Immunomodulators market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Oral
    Injectable
    Topical
    Others

Segmentation by Application:
    Online Sales
    Offline Sales

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Zoetis, Inc.
    Elanco Animal Health
    Boehringer Ingelheim Animal Health
    MSD Animal Health
    ImmunoVet Ltd.
    Vetoquinol S.A.
    Phibro Animal Health Corporation
    Ceva Santé Animale
    Biogenesis Bago

Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Immunomodulators market?
What factors are driving Veterinary Immunomodulators market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Immunomodulators market opportunities vary by end market size?
How does Veterinary Immunomodulators break out by Type, by Application?